These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 31000444
1. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Shiohara T, Mizukawa Y. Allergol Int; 2019 Jul; 68(3):301-308. PubMed ID: 31000444 [Abstract] [Full Text] [Related]
2. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease. Mizukawa Y, Hirahara K, Kano Y, Shiohara T. J Am Acad Dermatol; 2019 Mar; 80(3):670-678.e2. PubMed ID: 30240780 [Abstract] [Full Text] [Related]
5. Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS). Mizukawa Y, Kimishima M, Aoyama Y, Shiohara T. Int J Infect Dis; 2020 Nov; 100():239-246. PubMed ID: 32891735 [Abstract] [Full Text] [Related]
11. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. Mitsui Y, Shinkuma S, Nakamura-Nishimura Y, Ommori R, Ogawa K, Miyagawa F, Mori Y, Tohyama M, Asada H. J Allergy Clin Immunol Pract; 2022 Feb; 10(2):558-565.e4. PubMed ID: 34757063 [Abstract] [Full Text] [Related]
12. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms. Takehara A, Aoyama Y, Kurosawa M, Shirafuji Y, Umemura H, Kamiya K, Ushigome Y, Kano Y, Shiohara T, Iwatsuki K. Br J Dermatol; 2016 Nov; 175(5):944-952. PubMed ID: 27087170 [Abstract] [Full Text] [Related]
14. Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management. Shiohara T, Kano Y, Takahashi R, Ishida T, Mizukawa Y. Chem Immunol Allergy; 2012 Nov; 97():122-38. PubMed ID: 22613858 [Abstract] [Full Text] [Related]
15. Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Takamiyagi S, Iriki H, Asahina Y, Furuichi Y, Funakoshi T, Ichikawa M, Mikami Y, Okita H, Sakiyama T, Inazumi T, Amagai M, Takahashi H. J Dermatol; 2022 Aug; 49(8):796-799. PubMed ID: 35502510 [Abstract] [Full Text] [Related]
16. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome. Bohm KJ, Ciralsky JB, Harp JL, Bajaj S, Sippel KC. Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005 [Abstract] [Full Text] [Related]